Funds holding C4 Therapeutics Inc
ISIN US12529R1077 · United States
- Fund holders
- 49
- Of which ETFs
- 13 36 other funds
- Value held
- ≈ 28.3M $ 28.3M $ · 32.5K €
- Share of capital
- 8.7 % of 123M shares on Jul 31, 2026
| Fund | Shares | Value | Weight in fund | Share of capital | |
|---|---|---|---|---|---|
| VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS | 2,892,424 | 7.6M $ | 0.00 % | 2.35 % | as of Mar 31, 2026 ↗ |
| Wasatch Ultra Growth Fund WASATCH FUNDS TRUST | 2,649,322 | 7M $ | 1.73 % | 2.15 % | as of Mar 31, 2026 ↗ |
| VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS | 882,933 | 2.3M $ | 0.00 % | 0.72 % | as of Mar 31, 2026 ↗ |
| iShares Biotechnology ETF iShares Trust | 608,839 | 1.6M $ | 0.02 % | 0.49 % | as of Mar 31, 2026 ↗ |
| JNL Multi-Manager Small Cap Value Fund JNL Series Trust | 471,626 | 1.2M $ | 0.07 % | 0.38 % | as of Mar 31, 2026 ↗ |
| Schwab U.S. Small-Cap ETF SCHWAB STRATEGIC TRUST | 383,143 | 1M $ | 0.01 % | 0.31 % | as of Feb 28, 2026 ↗ |
| Fidelity Extended Market Index Fund Fidelity Concord Street Trust | 326,166 | 880.6K $ | 0.00 % | 0.27 % | as of Feb 28, 2026 ↗ |
| Dimensional U.S. Small Cap ETF Dimensional ETF Trust | 321,952 | 911.1K $ | 0.01 % | 0.26 % | as of Apr 30, 2026 ↗ |
| Wasatch Long/Short Alpha Fund WASATCH FUNDS TRUST | 243,988 | 641.7K $ | 1.80 % | 0.20 % | as of Mar 31, 2026 ↗ |
| Invesco RAFI US 1500 Small-Mid ETF Invesco Exchange-Traded Fund Trust | 212,398 | 601.1K $ | 0.02 % | 0.17 % | as of Apr 30, 2026 ↗ |
| iShares Micro-Cap ETF iShares Trust | 189,897 | 499.4K $ | 0.04 % | 0.15 % | as of Mar 31, 2026 ↗ |
| Fidelity Enhanced Small Cap ETF Fidelity Covington Trust | 160,029 | 420.9K $ | 0.01 % | 0.13 % | as of Mar 31, 2026 ↗ |
| Fidelity Total Market Index Fund Fidelity Concord Street Trust | 154,473 | 417.1K $ | 0.00 % | 0.13 % | as of Feb 28, 2026 ↗ |
| Ultra-Small Company Market Fund Bridgeway Funds, Inc. | 120,000 | 315.6K $ | 0.26 % | 0.10 % | as of Mar 31, 2026 ↗ |
| Fidelity Series Total Market Index Fund Fidelity Concord Street Trust | 112,583 | 304K $ | 0.00 % | 0.09 % | as of Feb 28, 2026 ↗ |
| U.S. MICRO CAP PORTFOLIO DFA INVESTMENT DIMENSIONS GROUP INC | 106,457 | 301.3K $ | 0.00 % | 0.09 % | as of Apr 30, 2026 ↗ |
| VIP Disciplined Small Cap Portfolio Variable Insurance Products Fund II | 92,760 | 244K $ | 0.05 % | 0.08 % | as of Mar 31, 2026 ↗ |
| Avantis U.S. Small Cap Equity ETF American Century ETF Trust | 76,099 | 205.5K $ | 0.01 % | 0.06 % | as of Feb 28, 2026 ↗ |
| T. Rowe Price Extended Equity Market Index Fund T. ROWE PRICE INDEX TRUST, INC. | 71,546 | 188.2K $ | 0.02 % | 0.06 % | as of Mar 31, 2026 ↗ |
| U.S. SMALL CAP PORTFOLIO DFA INVESTMENT DIMENSIONS GROUP INC | 64,229 | 181.8K $ | 0.00 % | 0.05 % | as of Apr 30, 2026 ↗ |
| Fidelity Nasdaq Composite Index Fund Fidelity Concord Street Trust | 61,523 | 166.1K $ | 0.00 % | 0.05 % | as of Feb 28, 2026 ↗ |
| VANGUARD BALANCED INDEX FUND VANGUARD VALLEY FORGE FUNDS | 45,085 | 118.6K $ | 0.00 % | 0.04 % | as of Mar 31, 2026 ↗ |
| Fidelity ZERO Total Market Index Fund Fidelity Concord Street Trust | 44,588 | 126.2K $ | 0.00 % | 0.04 % | as of Apr 30, 2026 ↗ |
| VANGUARD INSTITUTIONAL TOTAL STOCK MARKET INDEX FUND VANGUARD INSTITUTIONAL INDEX FUNDS | 41,410 | 108.9K $ | 0.00 % | 0.03 % | as of Mar 31, 2026 ↗ |
| Schwab Total Stock Market Index Fund SCHWAB CAPITAL TRUST | 40,958 | 115.9K $ | 0.00 % | 0.03 % | as of Apr 30, 2026 ↗ |
| Fidelity ZERO Extended Market Index Fund Fidelity Concord Street Trust | 28,086 | 79.5K $ | 0.00 % | 0.02 % | as of Apr 30, 2026 ↗ |
| Schwab U.S. Broad Market ETF SCHWAB STRATEGIC TRUST | 27,023 | 73K $ | 0.00 % | 0.02 % | as of Feb 28, 2026 ↗ |
| U.S. VECTOR EQUITY PORTFOLIO DFA INVESTMENT DIMENSIONS GROUP INC | 26,110 | 73.9K $ | 0.00 % | 0.02 % | as of Apr 30, 2026 ↗ |
| Invesco NASDAQ Future Gen 200 ETF Invesco Exchange-Traded Fund Trust II | 24,468 | 66.1K $ | 0.47 % | 0.02 % | as of Feb 28, 2026 ↗ |
| Dimensional U.S. Core Equity 2 ETF Dimensional ETF Trust | 21,949 | 62.1K $ | 0.00 % | 0.02 % | as of Apr 30, 2026 ↗ |
| Blackstone Alternative Multi-Strategy Fund Blackstone Alternative Investment Funds | 21,000 | 55.2K $ | 0.00 % | 0.02 % | as of Mar 31, 2026 ↗ |
| Dimensional US Core Equity Market ETF Dimensional ETF Trust | 19,202 | 54.3K $ | 0.00 % | 0.02 % | as of Apr 30, 2026 ↗ |
| 1290 VT Micro Cap Portfolio EQ Advisors Trust | 13,199 | 34.7K $ | 0.02 % | 0.01 % | as of Mar 31, 2026 ↗ |
| JNL/DFA U.S. Small Cap Fund JNL Series Trust | 13,165 | 34.6K $ | 0.00 % | 0.01 % | as of Mar 31, 2026 ↗ |
| Fidelity Flex Small Cap Index Fund Fidelity Salem Street Trust | 12,033 | 34.1K $ | 0.01 % | 0.01 % | as of Apr 30, 2026 ↗ |
| Goldman Sachs Absolute Return Tracker Fund GOLDMAN SACHS TRUST | 11,236 | 29.6K $ | 0.00 % | 0.01 % | as of Mar 31, 2026 ↗ |
| Avantis U.S. Small Cap Equity Fund American Century ETF Trust | 9,345 | 25.2K $ | 0.02 % | 0.01 % | as of Feb 28, 2026 ↗ |
| Victory Extended Market Index Fund Victory Portfolios III | 9,344 | 26.4K $ | 0.00 % | 0.01 % | as of Apr 30, 2026 ↗ |
| Dimensional US Core Equity 1 ETF Dimensional ETF Trust | 7,360 | 20.8K $ | 0.00 % | 0.01 % | as of Apr 30, 2026 ↗ |
| JNL/DFA U.S. Core Equity Fund JNL Series Trust | 7,056 | 18.6K $ | 0.00 % | 0.01 % | as of Mar 31, 2026 ↗ |
| AST Small-Cap Equity Portfolio Advanced Series Trust | 6,970 | 18.3K $ | 0.00 % | 0.01 % | as of Mar 31, 2026 ↗ |
| Invesco Nasdaq Biotechnology ETF Invesco Exchange-Traded Fund Trust II | 5,430 | 14.7K $ | 0.02 % | 0.00 % | as of Feb 28, 2026 ↗ |
| VIP Extended Market Index Portfolio Variable Insurance Products Fund II | 5,132 | 13.5K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Small Cap Core Fund Northern Funds | 4,640 | 12.2K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| ProShares Ultra Nasdaq Biotechnology ProShares Trust | 4,475 | 12.1K $ | 0.01 % | 0.00 % | as of Feb 28, 2026 ↗ |
| VIP Total Market Index Portfolio Variable Insurance Products Fund II | 2,206 | 5.8K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Total Stock Market Index Trust John Hancock Variable Insurance Trust | 1,839 | 4.8K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Knights of Columbus U.S. ALL CAP INDEX FUND ADVISORS' INNER CIRCLE III | 507 | 1.4K $ | 0.00 % | 0.00 % | as of Apr 30, 2026 ↗ |
| VIFAG 2002, SICAV S.A. GESALCALA, S.A., S.G.I.I.C. | 32.5K € | 0.04 % | as of Dec 31, 2025 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table counts shares; this one measures what the company weighs inside each fund.
| Fund | Weight in fund | |
|---|---|---|
| Wasatch Long/Short Alpha Fund WASATCH FUNDS TRUST | 1.80 % | as of Mar 31, 2026 ↗ |
| Wasatch Ultra Growth Fund WASATCH FUNDS TRUST | 1.73 % | as of Mar 31, 2026 ↗ |
| Invesco NASDAQ Future Gen 200 ETF Invesco Exchange-Traded Fund Trust II | 0.47 % | as of Feb 28, 2026 ↗ |
| Ultra-Small Company Market Fund Bridgeway Funds, Inc. | 0.26 % | as of Mar 31, 2026 ↗ |
| JNL Multi-Manager Small Cap Value Fund JNL Series Trust | 0.07 % | as of Mar 31, 2026 ↗ |
| VIP Disciplined Small Cap Portfolio Variable Insurance Products Fund II | 0.05 % | as of Mar 31, 2026 ↗ |
| iShares Micro-Cap ETF iShares Trust | 0.04 % | as of Mar 31, 2026 ↗ |
| VIFAG 2002, SICAV S.A. GESALCALA, S.A., S.G.I.I.C. | 0.04 % | as of Dec 31, 2025 ↗ |
| Invesco RAFI US 1500 Small-Mid ETF Invesco Exchange-Traded Fund Trust | 0.02 % | as of Apr 30, 2026 ↗ |
| Avantis U.S. Small Cap Equity Fund American Century ETF Trust | 0.02 % | as of Feb 28, 2026 ↗ |
Quarter after quarter
Each SEC quarterly data set, newest first. The change is read against the quarter before it.
| Quarter | Holders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q2 | 48 | +5 | 10,656,203 | +12.5 % |
| 2026Q1 | 43 | +3 | 9,470,555 | +12.0 % |
| 2025Q4 | 40 | -26 | 8,456,330 | -26.4 % |
| 2025Q3 | 66 | -46 | 11,482,487 | -23.8 % |
| 2025Q2 | 112 | -1 | 15,070,853 | +1.8 % |
| 2025Q1 | 113 | -10 | 14,801,330 | -7.0 % |
| 2024Q4 | 123 | +54 | 15,912,043 | +30.9 % |
| 2024Q3 | 69 | +13 | 12,155,247 | -27.6 % |
| 2024Q2 | 56 | -3 | 16,784,313 | +50.3 % |
| 2024Q1 | 59 | -6 | 11,170,919 | -1.8 % |
| 2023Q4 | 65 | 11,370,746 |
Institutional managers
118 managers declare this company to the SEC (Form 13F); the 25 largest follow.
| Manager | Shares | Value | |
|---|---|---|---|
| MORGAN STANLEY | 9,072,400 | 23.9M $ | as of Mar 31, 2026 |
| RA CAPITAL MANAGEMENT, L.P. | 8,000,000 | 21M $ | as of Mar 31, 2026 |
| Bain Capital Life Sciences Investors, LLC | 7,171,910 | 18.9M $ | as of Mar 31, 2026 |
| Lynx1 Capital Management LP | 6,998,902 | 18.4M $ | as of Mar 31, 2026 |
| Soleus Capital Management, L.P. | 3,803,942 | 10M $ | as of Mar 31, 2026 |
| JPMORGAN CHASE & CO | 3,223,054 | 7.6M $ | as of Mar 31, 2026 |
| TWO SIGMA INVESTMENTS, LP | 3,035,634 | 8M $ | as of Mar 31, 2026 |
| WASATCH ADVISORS LP | 2,961,761 | 7.8M $ | as of Mar 31, 2026 |
| CITADEL ADVISORS LLC | 2,511,015 | 6.6M $ | as of Mar 31, 2026 |
| RENAISSANCE TECHNOLOGIES LLC | 2,461,815 | 6.5M $ | as of Mar 31, 2026 |
| GOLDMAN SACHS GROUP INC | 2,387,378 | 6.3M $ | as of Mar 31, 2026 |
| BANK OF AMERICA CORP /DE/ | 2,359,241 | 6.2M $ | as of Mar 31, 2026 |
| Squadron Capital Management LLC | 2,250,000 | 5.9M $ | as of Mar 31, 2026 |
| BlackRock, Inc. | 2,048,526 | 5.4M $ | as of Mar 31, 2026 |
| SILVERARC CAPITAL MANAGEMENT, LLC | 1,911,785 | 5M $ | as of Mar 31, 2026 |
| ACADIAN ASSET MANAGEMENT LLC | 1,890,914 | 5K $ | as of Mar 31, 2026 |
| MILLENNIUM MANAGEMENT LLC | 1,393,342 | 3.7M $ | as of Mar 31, 2026 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 1,286,840 | 3.4M $ | as of Mar 31, 2026 |
| JANE STREET GROUP, LLC | 1,246,896 | 3.3M $ | as of Mar 31, 2026 |
| D. E. Shaw & Co., Inc. | 1,060,331 | 2.8M $ | as of Mar 31, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | 951,043 | 2.5M $ | as of Mar 31, 2026 |
| WELLS FARGO & COMPANY/MN | 867,911 | 2.3M $ | as of Mar 31, 2026 |
| ORBIMED ADVISORS LLC | 856,353 | 2.3M $ | as of Mar 31, 2026 |
| CONGRESS ASSET MANAGEMENT CO | 830,624 | 2.2M $ | as of Mar 31, 2026 |
| Qube Research & Technologies Ltd | 752,114 | 2M $ | as of Mar 31, 2026 |
Declared shareholders of C4 Therapeutics Inc
4 beneficial ownership filings. These stakes do not add up: an asset manager filing aggregates its own funds, already counted above.
| Shareholder | Declared stake | Shares | |
|---|---|---|---|
| Sirenia Capital Management LP and 1 other | 9.90 % | 23,505,000 | as of Mar 31, 2026 · SCHEDULE 13G |
| Squadron Master Fund LP and 3 others | 5.00 % | 5,550,000 | as of May 12, 2026 · SCHEDULE 13G |
| Wasatch Advisors LP | 4.70 % | 4,581,761 | as of Mar 31, 2026 · SCHEDULE 13G |
| Point72 Asset Management, L.P. and 2 others | 0.20 % | 169,096 | as of Mar 31, 2026 · SCHEDULE 13G |
Cite this page
Titelia. "Funds holding C4 Therapeutics Inc". https://titelia.com/en/stocks/c4-therapeutics-inc-US12529R1077